share_log

譚仔國際:截至二零二四年二月二十九日止之股份發行人的證券變動月報表

TAM JAI INTL: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 5 03:46
Summary by Moomoo AI
譚仔國際有限公司於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表,涵蓋2024年2月份的股份變動情況。報告顯示,該公司於2021年3月25日採納的首次公開發售前後購股權計劃下,本月內有8,800股份期權被行使,導致普通股股份數目增加,並為公司帶來了7,480港元的資金。此外,報告確認所有新發行的證券均已獲得董事會的正式授權,並符合香港聯合交易所有限公司證券上市規則的相關要求。
譚仔國際有限公司於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表,涵蓋2024年2月份的股份變動情況。報告顯示,該公司於2021年3月25日採納的首次公開發售前後購股權計劃下,本月內有8,800股份期權被行使,導致普通股股份數目增加,並為公司帶來了7,480港元的資金。此外,報告確認所有新發行的證券均已獲得董事會的正式授權,並符合香港聯合交易所有限公司證券上市規則的相關要求。
Tan Chai International Limited submitted its latest Securities Monthly Change Report to Hong Kong Trading and Settlement Limited on 5 March 2024, covering the stock changes for February 2024. The report showed that 8,800 share options were exercised this month under the company's initial public offering and offering on 25 March 2021, resulting in an increase in the number of ordinary shares and raising HK$7,480 in capital for the company. In addition, the report confirms that all newly issued securities have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Tan Chai International Limited submitted its latest Securities Monthly Change Report to Hong Kong Trading and Settlement Limited on 5 March 2024, covering the stock changes for February 2024. The report showed that 8,800 share options were exercised this month under the company's initial public offering and offering on 25 March 2021, resulting in an increase in the number of ordinary shares and raising HK$7,480 in capital for the company. In addition, the report confirms that all newly issued securities have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more